Jane F. Barlow

Jane F. Barlow, MD, MPH, MBA, currently serves as a member of the Board of Directors for Sera Prognostics and Viracta, and as CEO of Jane Barlow & Associates, LLC, providing consulting services to optimize clinical and financial outcomes for various health-related companies. Additionally, Jane holds the position of EVP and Chief Clinical Officer at Real Endpoints and serves as a Senior Advisor for the MIT NEWDIGS, FoCUS Project, while having held board director roles at several organizations, including ContraFect Corp, Momenta Pharmaceuticals, TherapeuticsMD, and SilverScript Insurance Company. Their previous experience also includes serving as Chief Medical Officer for CVS Health's Government Services segment. Jane's educational background includes an MD from Creighton University, an MBA from the University of Alabama, and an MPH from The Johns Hopkins School of Public Health, specializing in Occupational Medicine.